Syntone Ventures LLC

Insider Reports History

Location
Cary, NC
Signature
/s/ Jiahui Zheng, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Syntone Ventures LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Outlook Therapeutics, Inc. 10%+ Owner Common Stock 1,705,438 $716,284 $0.4200 15 Apr 2024 Direct
Outlook Therapeutics, Inc. 10%+ Owner Warrant (Right to Buy) 1,071,429 15 Apr 2024 Direct

Insider Reports Filed by Syntone Ventures LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OTLK Outlook Therapeutics, Inc. 15 Apr 2024 2 $0 4 10%+ Owner 17 Apr 2024, 20:21